A corporate integrity agreement (CIA) is frequently a part of civil settlements between the Office of the Inspector General of the U.S. Department of Health and Human Resources (OIG) and a health care provider or entity, including pharmaceutical companies. By entering into the CIA, a provider or entity agrees to various obligations in exchange for the OIG's agreement that it will not seek to exclude the provider or entity from participation in Medicare, Medicaid or other federal health care programs.